Verigraft

About Verigraft

Verigraft develops personalized tissue-engineered grafts for transplantation, including veins, arteries, nerves and heart valves. The company focuses on making donor tissues resemble the patient’s own to reduce rejection and immunosuppression, aiming to improve outcomes in transplantation. It is based in Gothenburg, Sweden, and emphasizes clinical trials and innovative regenerative medicine approaches to address previously incurable diseases.